Indorama Ventures 1st Quarter 2019 MD&A 1 Indorama Ventures Public Company Ltd Management Discussion and Analysis 1st Quarter 2019 Highlights Revenue $3.0 billion (THB 95.8 billion), +26% YoY Core EBITDA
. Investment in raw material extraction plant and world-class research laboratory 100 100 100 - 2018-2019 2. Development of the Company’s new brand 200 200 200 - 2018-2020 บริษัท ดีโอดี ไบโอเทค จ ำกัด (มหำชน
percent Purposes of use of proceeds disclosed in the registration statement for offer for sale of securities and draft prospectus 1. Investment in raw material extraction plant and world-class research
of water supply. Therefore the Company has seen the opportunities to expand into the water supply business in this area in order to create the additional revenue to the normal business. Furthermore
proven beneficial through the various supply chain disruptions seen this quarter, notably the Polar Vortex and Suez Canal blockage. Having access to our own raw material has allowed us to operate at higher
’ operating results for the year ended December 31st 2017 EBITDA Structure of the Company and its subsidiaries Q4/2016 Q3/2017 Q4/2017 YoY QoQ FY2016 FY2017 YoY Total Revenue 40,481 39,009 46,306 14% 19
imports of capital goods and raw materials. This was in line with the improving business sentiment and export recovery. The value of Thai exports for the first two months of 2021 fell by 1.2% yoy. Excluding
nine months, PET has faced considerable secondary raw material price increase from Isophthalic Ac- id (IPA) impacting 2Q17 PET segment by $13 per ton on YoY basis. Since IPA is a secondary feedstock, it
to levels last seen in 2015/16 as reflected in third quarter earnings. This has been achieved despite being negatively impacted by the cost increase from secondary raw material IPA by about $10 per ton
31 December 2019 in comparison with the corresponding period last year ended 31 December 2018 1 Revenue from sales Total revenue from sales were THB 14,933 million, an increase of THB 511 million or